Renal dysfunction and increased risk of cardiotoxicity with trastuzumab therapy: A new challenge in cardio-oncology

Internal and Emergency Medicine

Volumn 7, Issue 5, 2012, Pages 399-401

  Albini, Adriana ^a,c   Donatelli, Francesco ^b,c   Focaccetti, Chiara ^c   D'Elios, Mario Milco ^d   Noonan, Douglas M ^c,e  

^a S MARIA NUOVA HOSPITAL   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c IRCCS MULTIMEDICA   (Italy)

^d UNIVERSITY OF FLORENCE   (Italy)

^e UNIVERSITY OF INSUBRIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; MONOCLONAL ANTIBODY; TRASTUZUMAB;

BREAST TUMOR; CHEMICALLY INDUCED DISORDER; EDITORIAL; FEMALE; HEART DISEASE; HUMAN; KIDNEY FAILURE;

ANTIBODIES, MONOCLONAL, HUMANIZED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; FEMALE; HEART DISEASES; HUMANS; RENAL INSUFFICIENCY;

EID: 84866559376     PISSN: 18280447     EISSN: 19709366     Source Type: Journal    
DOI: 10.1007/s11739-012-0845-2     Document Type: Editorial

References (13)

1. Albini A, Pennesi G, Donatelli F, Cammarota R, De Flora S, Noonan DM (2010) Cardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological prevention. J Nat Cancer Inst 102: 14-25.
2. Ewer MS, Ewer SM (2010) Cardiotoxicity of anticancer treatments: what the cardiologist needs to know. Nat Rev Cardiol 7: 564-575.
3. Albini A, Donatelli F, Noonan D, D'Elios MM, Prisco D (2012) Bringing new players into the field: onco-pharmacovigilance in the era of cardio-oncology. Intern Emerg Med 7: 99-101.
4. Albini A, Cesana E, Donatelli F, Cammarota R, Bucci EO, Baravelli M et al (2011) Cardio-oncology in targeting the HER receptor family: the puzzle of different cardiotoxicities of HER2 inhibitors. Future Cardiol 7: 693-704.
5. Russo G, Cioffi G, Di Lenarda A, Tuccia F, Bovelli D, Di Tano G et al (2012) Role of renal function on development of cardiotoxicity associated with trastuzumab-based adjuvant chemotherapy for early breast cancer. Intern Emerg Med. doi: 10. 1007/s11739-012-0794-9.
6. Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE et al (2010) Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 375: 2073-2081.
7. Hering D, Mahfoud F, Walton AS, Krum H, Lambert GW, Lambert EA et al (2012) Renal denervation in moderate to severe CKD. J Am Soc Nephrol 23(7): 1250-1257.
8. Eriksen BO, Ingebretsen OC (2006) The progression of chronic kidney disease: a 10-year population-based study of the effects of gender and age. Kidney Int 69: 375-382.
9. O'Hare AM, Choi AI, Bertenthal D, Bacchetti P, Garg AX, Kaufman JS et al (2007) Age affects outcomes in chronic kidney disease. J Am Soc Nephrol 18: 2758-2765.
10. Giannelli SV, Patel KV, Windham BG, Pizzarelli F, Ferrucci L, Guralnik JM (2007) Magnitude of underascertainment of impaired kidney function in older adults with normal serum creatinine. J Am Geriatr Soc 55: 816-823.
11. Giannelli SV, Graf CE, Herrmann FR, Michel JP, Patel KV, Pizzarelli F et al (2011) Natural history of older adults with impaired kidney function: the InCHIANTI study. Rejuvenation Res 14: 513-523.
12. Ble A, Fink JC, Woodman RC, Klausner MA, Windham BG, Guralnik JM et al (2005) Renal function, erythropoietin, and anemia of older persons: the InCHIANTI study. Arch Intern Med 165: 2222-2227.
13. Raschi E, De Ponti F (2012) Cardiovascular toxicity of anticancer-targeted therapy: emerging issues in the era of cardio-oncology. Intern Emerg Med 7: 113-131.